当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis—are we there yet? Authors' reply
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-12-30 , DOI: 10.1111/apt.16726 Juan Antonio Sorda 1 , Esteban González Ballerga 1 , Fernando Javier Barreyro 2 , Jorge Daruich 1
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-12-30 , DOI: 10.1111/apt.16726 Juan Antonio Sorda 1 , Esteban González Ballerga 1 , Fernando Javier Barreyro 2 , Jorge Daruich 1
Affiliation
This article is linked to Sorda et al papers. To view these articles, visit https://doi.org/10.1111/apt.16618 and https://doi.org/10.1111/apt.16657
中文翻译：
社论：苯扎贝特治疗原发性胆汁性胆管炎——我们到了吗？作者的回复
本文链接到 Sorda 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.16618 和 https://doi.org/10.1111/apt.16657
更新日期：2021-12-31
中文翻译：
社论：苯扎贝特治疗原发性胆汁性胆管炎——我们到了吗？作者的回复
本文链接到 Sorda 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.16618 和 https://doi.org/10.1111/apt.16657
京公网安备 11010802027423号